Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DW0VB7
|
|||
| Drug Name |
JNJ-80948543
|
|||
| Synonyms |
JNJ-8543
Click to Show/Hide
|
|||
| Indication | Haematological malignancy [ICD-11: 2B33.Y] | Phase 1 | [1] | |
| Company |
JOHNSON & JOHNSON
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05424822) A Phase 1, First-in-human Study of JNJ-80948543, a T-cell Redirecting Antibody, in Participants With NHL and CLL. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.